Pembrolizumab,Lenvatinib,Sunitinib,Everolimus,Axitinib
Merck,Pfizer,eisai
['rcc,(-irccs),(-srcc),(-urcc)']
what is the best 1st-line combo for favorable risk patients with met rcc? un-clear but no tki mono-tx in my view #asco23 
Oncólogo médico en @parctauli y Hospital de Barcelona. Vocal de la Junta Directiva de @sogug1. Wine lover. Life-enjoying!